drugset / Trial / NCT07548632
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.
Timeline
- Start
- 2026-04-16
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | licaminlimab | Monoclonal antibody | 60 mg/ml | Topical |